Ranbaxy Recalls Atorvastatin Calcium Tablets Due to Foreign Tablet Presence
Ranbaxy Inc. is recalling 64,626 bottles of Atorvastatin Calcium 10 mg tablets because a 20 mg tablet was found inside a sealed 10 mg bottle.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class II, which typically involves a situation where use of, or exposure to, the product may cause temporary or medically reversible health consequences. The presence of a foreign tablet of a different strength represents a potential dosing error risk, but no injuries or illnesses have been reported in the source text.
Plain-English summary
Ranbaxy Inc. is recalling 64,626 bottles of Atorvastatin Calcium Tablets, 10 mg, 90-count, Rx only. The recall was initiated after a pharmacist reported finding an Atorvastatin 20 mg tablet inside a sealed bottle of 90-count Atorvastatin 10 mg tablets.
The affected product is identified by NDC 63304-827-90 and lot codes 2407255 and 2407256, with an expiration date of 05/14. The product was distributed nationwide. The manufacturer is Ranbaxy Pharmaceuticals Inc., Jacksonville, FL, and it was manufactured by Ranbaxy Laboratories Ltd., New Delhi, India.
Consumers and healthcare providers should check their inventory for the specific lot codes and expiration date listed above. If the product is found, it should be returned to the pharmacy or supplier for replacement or refund. Patients should consult their healthcare provider if they have questions regarding their medication.
The recalled product
- Product
- ATORVASTATIN CALCIUM (ATORVASTATIN CALCIUM)
- Brand
- ATORVASTATIN CALCIUM
- Manufacturer
- Ranbaxy Inc.
- Category
- Drug — Prescription Drug
- Affected units
- 64,626
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- 2407255
- 2407256 Exp. 05/14
UPCs (1)
- 633048279024
Distribution
Distributed nationwide across the United States.
Related recalls
Same brand · ATORVASTATIN CALCIUM
- ModerateAtorvastatin 20 mg tablets recalled after failing dissolution specifications
FDA (Drugs) · 2025-10-22
- ModerateAtorvastatin 40 mg tablets recalled after failing dissolution specifications
FDA (Drugs) · 2025-10-22
- ModerateAtorvastatin 10 mg tablets recalled after failing dissolution specifications
FDA (Drugs) · 2025-10-22
- ModerateAtorvastatin 80 mg tablets recalled after failing dissolution specifications
FDA (Drugs) · 2025-10-22
- HighBiocon Pharma atorvastatin calcium tablets recalled for failed dissolution specifications
FDA (Drugs) · 2025-04-09
Same manufacturer · Ranbaxy Inc.
See all →- ModerateRanbaxy Recalls Absorica LD Isotretinoin Capsules Due to Undeclared Dye
FDA (Drugs) · 2015-08-12
- LowRanbaxy Recalls Lac-Hydrin Cream Due to Crystallization
FDA (Drugs) · 2013-02-20
- LowRanbaxy Recalls Lac-Hydrin Lotion Due to Crystallization Texture
FDA (Drugs) · 2013-02-20
- SevereRanbaxy Recalls Atorvastatin Calcium Tablets Due to Glass Particulates
FDA (Drugs) · 2012-12-05
- SevereRanbaxy Recalls Atorvastatin Calcium Tablets Due to Glass Particulates
FDA (Drugs) · 2012-12-05
Same hazard · foreign object
See all →- SevereOutshine Strawberry Fruit Bars Recalled for Potential Glass Contamination
FDA (Food) · 2026-09-02
- SevereOutshine Black Cherry Fruit Bars Recalled for Potential Glass Contamination
FDA (Food) · 2026-09-02
- SevereOutshine Fruit Bars Recalled for Potential Glass Contamination
FDA (Food) · 2026-09-02
- SevereOutshine Fruit Bars Grape Recalled for Potential Glass Contamination
FDA (Food) · 2026-09-02
- SevereOutshine Watermelon Fruit Bars Recalled for Potential Glass Contamination
FDA (Food) · 2026-09-02